Related Experiment Videos
Ovarian cancer
1Rush Presbyterian, St Lukes Medical Center, Chicago, IL.
Abstract:
Prevention, early detection, morbidity, and survival issues continue to challenge health professionals involved in the care of women with ovarian cancer. While advances in diagnosis, staging, and treatment have been made, survival rates remain grim. Continuing research in the areas of screening, diagnosis, and treatment is the key to improved survival. The hope of new drug therapy, such as cisplatin-taxol regimens, intraperitoneal therapy, immunotherapy, and bone marrow transplantation, needs further investigation to become reality. As new and potentially more toxic regimens are developed, the nurse must be knowledgeable about the therapies and adverse effects, and maintain a high level of clinical expertise in order to teach the patient, reinforce information, clarify misconceptions, and provide the patient with supportive physical and emotional care.
Insights
Improving ovarian cancer survival hinges on advancements in screening, diagnosis, and treatment. Continued research into novel therapies and supportive nursing care is crucial for better patient outcomes.
Area of Science:
- Gynecologic Oncology
- Cancer Research
- Patient Care
Background:
- Ovarian cancer presents persistent challenges in prevention, early detection, morbidity, and survival.
- Despite diagnostic and therapeutic progress, survival rates for ovarian cancer remain low.
Purpose of the Study:
- To highlight the critical need for ongoing research in ovarian cancer screening, diagnosis, and treatment.
- To emphasize the importance of investigating novel therapeutic strategies and supportive care for patients.
Main Methods:
- Review of current challenges and advances in ovarian cancer care.
- Discussion of emerging treatment modalities and their investigational status.
- Emphasis on the role of nursing in patient education and support.
Main Results:
- Survival rates for ovarian cancer have not significantly improved despite advances.
- New drug therapies like cisplatin-taxol, intraperitoneal therapy, immunotherapy, and bone marrow transplantation show potential but require further investigation.
- Nursing expertise is vital for managing complex treatments and providing comprehensive patient support.
Conclusions:
- Continued research is essential for improving ovarian cancer survival rates.
- Novel therapeutic regimens require rigorous investigation to establish efficacy and safety.
- Nurses play a pivotal role in educating patients about new treatments and providing critical physical and emotional support.